Capital International, Inc. Zai Lab LTD Transaction History

Capital International, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$15.95 - $26.8 $92,749 - $155,842	5,815 Added 6.74%	92,108 $1.48 Million
Q4 2023 Feb 13, 2024	SELL	$22.97 - $30.58 $103,824 - $138,221	-4,520 Reduced 4.98%	86,293 $2.36 Million
Q3 2023 Nov 13, 2023	SELL	$22.72 - $31.49 $7.93 Million - $11 Million	-349,105 Reduced 79.36%	90,813 $2.21 Million
Q2 2023 Aug 11, 2023	SELL	$25.3 - $39.67 $17.9 Million - $28 Million	-705,692 Reduced 61.6%	439,918 $12.2 Million
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $9.82 Million - $15.6 Million	325,008 Added 39.61%	1,145,610 $38.1 Million
Q4 2022 Feb 14, 2023	SELL	$22.28 - $38.71 $419,354 - $728,599	-18,822 Reduced 2.24%	820,602 $25.2 Million
Q3 2022 Nov 14, 2022	BUY	$34.2 - $51.69 $311,938 - $471,464	9,121 Added 1.1%	839,424 $28.7 Million
Q2 2022 Aug 15, 2022	SELL	$23.14 - $49.68 $837,066 - $1.8 Million	-36,174 Reduced 4.17%	830,303 $28.8 Million
Q1 2022 May 16, 2022	BUY	$27.77 - $64.4 $22.3 Million - $51.7 Million	802,622 Added 1256.94%	866,477 $38.1 Million
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $46,225 - $88,586	-842 Reduced 1.3%	63,855 $4.01 Million
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $156,660 - $266,128	1,492 Added 2.36%	64,697 $6.82 Million
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $7.91 Million - $11.4 Million	63,205 New	63,205 $11.2 Million

117

40.9M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.58B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

Stay updated on Capital International, Inc. with notifications on news.